The NOrthern MAnhattan Study (NOMAS)

General Information

Name: 
The NOrthern MAnhattan Study
Short Name: 
NOMAS
Where was the information about this study obtained from?: 
Publicly available sources of information
Marker paper: 
Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263–2269.

Methods

Study Design: 
Prospective cohort study
Recruitment start date: 
January, 1993
Is recruitment continuing?: 
No
Recruitment end date: 
August, 2001
Type of people (individuals, families, twins etc.) targeted by the study design: 
Individuals
Target number of participants to be recruited to the study: 
3 298
Actual number of participants recruited to the study: 
3 298
recorded on Aug 2001

Broad categories of ethnic and racial groups recruited

Approximate number of participants that are of Hispanic or Latino origin: 
1560

Approximate number of participants in each main racial group represented in the study:
African / African-American / Black: 
696
European / White: 
614
Genotype Arrays: 
Genotyping platform: 
Affymetrix 6.0 (1M chip)

Available Information

Health Information: 
Anthropometric traits (e.g. BMI, waist circumference) at baseline
Glycaemic traits (e.g. glucose, insulin) at baseline
Prevalent type 2 diabetes at baseline
Does the study have any measures of diet?: 
Yes
Does the study have any measures of physical activity?: 
Yes
Does the study have DNA extracted or have a potential source of DNA?: 
Yes

Populations from which the sample(s) is drawn

Sampling Frame 1

Selection criteria: 
Gender:
Women and Men
Age:
Minimum 40
Country:
United States
Area of residence:
Urban
Pregnant women:
No
Newborn:
No
Migration status:
No
Other selection criteria:

NOMAS participants had never been diagnosed with a stroke, were at least 40 years of age, and resided for at least 3 months in a household with a telephone in Northern Manhattan.

Sources of recruitment: 
General population